Financiers with a great deal of cash to invest have actually taken a bearish position on Recursion Pharmaceuticals RXRX
And retail traders need to understand.
We discovered this today when the positions appeared on openly offered alternatives history that we track here at Benzinga.
Whether these are organizations or simply rich people, we do not understand. However when something this huge occurs with RXRX, it typically implies someone understands something will occur.
Today, Benzinga’s alternatives scanner found 14 alternatives trades for Recursion Pharmaceuticals
This isn’t regular.
The total belief of these big-money traders is divided in between 28% bullish and 35%, bearish.
Out of all of the alternatives we discovered, there was 1 put, for an overall quantity of $28,225, and 13, calls, for an overall quantity of $916,047.
Trending Financial Investment Opportunities
Anticipated Rate Motions
Based upon the trading activity, it appears that the substantial financiers are going for a cost area extending from $3.0 to $17.0 for Recursion Pharmaceuticals over the current 3 months.
Examining Volume & & Open Interest
Examining the volume and open interest is a tactical action in alternatives trading. These metrics clarified the liquidity and financier interest in Recursion Pharmaceuticals’s alternatives at defined strike rates. The upcoming information pictures the variation in volume and open interest for both calls and puts, connected to Recursion Pharmaceuticals’s considerable trades, within a strike rate spectrum from $3.0 to $17.0 over the preceding 1 month.
Recursion Pharmaceuticals 30-Day Alternative Volume & & Interest Photo
Most Significant Options Identified:
| Sign | PUT/CALL | Trade Type | Belief | Exp. Date | Ask | Quote | Rate | Strike Rate | Overall Trade Rate | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RXRX | CALL | SWEEP | NEUTRAL | 07/25/25 | $ 0.45 | $ 0.4 | $ 0.4 | $ 6.50 | $ 182.4 K | 1.8 K | 5.0 K |
| RXRX | CALL | SWEEP | BEARISH | 09/19/25 | $ 0.5 | $ 0.45 | $ 0.45 | $ 10.00 | $ 180.0 K | 3.7 K | 5.1 K |
| RXRX | CALL | SWEEP | NEUTRAL | 09/19/25 | $ 1.65 | $ 1.55 | $ 1.6 | $ 6.00 | $ 163.8 K | 11.9 K | 2.3 K |
| RXRX | CALL | SWEEP | BULLISH | 07/25/25 | $ 0.85 | $ 0.75 | $ 0.8 | $ 6.00 | $ 56.3 K | 15.2 K | 2.8 K |
| RXRX | CALL | TRADE | NEUTRAL | 07/25/25 | $ 1.15 | $ 1.05 | $ 1.1 | $ 6.00 | $ 55.0 K | 15.2 K | 9.7 K |
About Recursion Pharmaceuticals
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology business. The business is deciphering biology by incorporating technological developments throughout biology, chemistry, automation, information science, and engineering, with the objective of significantly enhancing the lives of clients and industrializing drug discovery.
Existing Position of Recursion Pharmaceuticals
- Presently trading with a volume of 65,934,254, the RXRX’s rate is up by 11.62%, now at $6.52.
- RSI readings recommend the stock is presently might be approaching overbought.
- Prepared for revenues release remains in 17 days.
What The Professionals State On Recursion Pharmaceuticals
In the last month, 2 specialists launched rankings on this stock with a typical target rate of $6.5.
Unusual Options Activity Detected: Smart Cash on the Move
Benzinga Edge’s Unusual Options board areas possible market movers before they occur. See what positions huge cash is handling your preferred stocks. Click on this link for gain access to
* In a mindful relocation, an expert from Needham reduced its ranking to Purchase, setting a cost target of $8.
* In a mindful relocation, an expert from Morgan Stanley reduced its ranking to Equal-Weight, setting a cost target of $5.
Choices are a riskier property compared to simply trading the stock, however they have greater revenue capacity. Major alternatives traders handle this danger by informing themselves daily, scaling in and out of trades, following more than one sign, and following the marketplaces carefully.
If you wish to remain upgraded on the most recent alternatives trades for Recursion Pharmaceuticals, Benzinga Pro provides you real-time alternatives trades signals.